Bile acid receptor could be innovative target in protecting the vision of premature newborns
Targeting that receptor could provide earlier, more impactful treatments for retinopathy of prematurity.
We welcome investigators, students, trainees, research sponsors, and our community to explore our research web pages for content related to technology commercialization, sponsored programs, animal research, and human subject research. Learn more about our expanding research infrastructure, including InfoEd, eSProute, IRBNet, eSirius3G, OnCore, and iLab.
The glossary section explains acronyms and terms and research policies for research units. Research forms, policies, and guidelines can be found in Tools for Researchers. We encourage participation in our many training and education programs, research initiation processes, grant writing assistance, pilot funding opportunities, and clinical trial listings available for research participation.
Targeting that receptor could provide earlier, more impactful treatments for retinopathy of prematurity.
Retinopathy of prematurity (ROP) is among the most common illnesses that affect premature or low birth-weight infants and is a major cause of long-term vision impairment and blindness.
Antiretroviral cocktails can make human immunodeficiency virus, or HIV, undetectable and untransmittable, but both the virus and its treatment can also accelerate aging of bone and muscle.
Patients come to Amol Sharma, MD, because their stomachs constantly hurt, they are always nauseous and they can’t or won’t eat or drink